Clincosm LogoSign in Get a demo

Recurrent Glioblastoma

Showing 26 - 50 of 97
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn
  • Recurrent Anaplastic Astrocytoma
  • +7 more
  • Neural Stem Cells-expressing CRAd-S-pk7
  • Resection
  • (no location specified)
Nov 22, 2022

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

Active, not recruiting
  • Glioblastoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 16, 2022

Intracranial Tumor, Low Grade Glioma, Recurrent Glioblastoma Trial in San Francisco (F-18 Fluoroethyltyrosine (FET), Positron

Recruiting
  • Intracranial Neoplasm
  • +4 more
  • F-18 Fluoroethyltyrosine (FET)
  • Positron Emission Tomography (PET)
  • San Francisco, California
    University of California, San Francisco
Nov 7, 2022

Recurrent Glioblastoma Trial in Beijing (Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous

Not yet recruiting
  • Recurrent Glioblastoma
  • Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes.
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Oct 10, 2022

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Recurrent Glioblastoma Trial in Miami (Intensity Modulated Proton Therapy (IMPT), Bevacizumab)

Recruiting
  • Recurrent Glioblastoma
  • Miami, Florida
    University of Miami
Sep 30, 2022

Glioblastoma, Recurrent Glioblastoma Trial in Iowa City (Static Magnetic and Electric (sBE) device, Lomustine, Bevacizumab)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Static Magnetic and Electric (sBE) device
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 20, 2022

Recurrent Glioblastoma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)

Recruiting
  • Recurrent Glioblastoma
  • Tislelizumab plus Bevacizumab
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Sep 11, 2022

Gliosarcoma, Recurrent Glioblastoma Trial in Chicago (Laboratory Biomarker Analysis, Pharmacological Study, Targeted Molecular

Completed
Has Results
  • Gliosarcoma
  • Recurrent Glioblastoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Chicago, Illinois
    Northwestern University
Aug 5, 2022

Astrocytoma, Glioblastoma, Glioblastoma, IDH-Wildtype Trial in Chicago (drug, other, radiation)

Recruiting
  • Astrocytoma
  • +4 more
  • Mycophenolate Mofetil
  • +3 more
  • Chicago, Illinois
    Northwestern University
Aug 22, 2022

Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • Los Angeles, California
  • +18 more
Aug 16, 2022

Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)

Recruiting
  • Glioblastoma
  • +5 more
  • Ipilimumab
  • +4 more
  • Birmingham, Alabama
  • +19 more
Aug 16, 2022

Recurrent Glioblastoma Trial in Stanford, Orlando, Heidelberg (TTAC-0001)

Terminated
  • Recurrent Glioblastoma
  • Stanford, California
  • +2 more
Aug 15, 2022

Recurrent Glioblastoma Trial in Heidelberg, Nedlands (TTAC-0001 and pembrolizumab combination)

Active, not recruiting
  • Recurrent Glioblastoma
  • TTAC-0001 and pembrolizumab combination
  • Heidelberg, Victoria, Australia
  • +1 more
Aug 15, 2022

Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)

Recruiting
  • Glioblastoma Multiforme
  • Recurrent Glioblastoma
  • TheraSphere GBM
  • San Francisco, California
  • +4 more
Aug 15, 2022

IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal

Terminated
Has Results
  • IDH Family Wildtype
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Recurrent Glioblastoma, Recurrent Astrocytoma, Recurrent Oligodendroglioma Trial in Oklahoma City (Niraparib)

Recruiting
  • Recurrent Glioblastoma
  • +3 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jul 20, 2022

Glioblastoma, Recurrent Glioblastoma Trial in Boston (Pembrolizumab, Olaparib, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Boston, Massachusetts
  • +2 more
Jul 14, 2022

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Santa Monica (Radiation: Intra-operative Radiation Therapy - IORT,

Recruiting
  • Glioblastoma
  • +3 more
  • Radiation: Intra-operative Radiation Therapy - IORT
  • +2 more
  • Santa Monica, California
    Providence Saint John's Health Center
Jul 14, 2022

Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Astrocytoma, Grade IV Trial in Ann Arbor (drug, radiation, procedure)

Recruiting
  • Recurrent Glioblastoma
  • +5 more
  • Mycophenolate Mofetil
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jul 7, 2022

Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
Jul 1, 2022

Recurrent Glioblastoma Trial in Beijing (ASC40 tablets, Placebo tablets, Bevacizumab)

Recruiting
  • Recurrent Glioblastoma
  • ASC40 tablets
  • +2 more
  • Beijing, Beijing, China
    Beijing Tiantan Hospital，Capital Medical University
Jun 28, 2022

Recurrent Glioblastoma Trial in United States (Bevacizumab, Cediranib, Cediranib Maleate)

Active, not recruiting
  • Recurrent Glioblastoma
  • Bevacizumab
  • +3 more
  • La Jolla, California
  • +26 more
Jun 28, 2022

Glioblastoma, Recurrent Disease, Recurrent Glioblastoma Trial in Calgary (Afatinib, Dasatinib, Palbociclib)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Jun 24, 2022

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting
  • Recurrent Anaplastic Astrocytoma
  • +6 more
  • Carboxylesterase-expressing Allogeneic Neural Stem Cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022